Clinical Trials Directory

Trials / Unknown

UnknownNCT05583396

Pulmonary Diffusing Capacity During Acute Exercise in Patients With COPD

Pulmonary Diffusing Capacity to Nitric Oxide and Carbon Monoxide During Exercise in Patients With Chronic Obstructive Pulmonary Disease: a Test-retest Reliability Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
15 (estimated)
Sponsor
Rigshospitalet, Denmark · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The combined measurement of the pulmonary diffusing capacity to carbon monoxide (CO) and nitric oxide (NO) (DLCO/NO) during exercise may be a useful physiological measure of alveolar-capillary reserve in patients with Chronic obstructive pulmonary disease (COPD). The present study investigated the test-retest reliability of DLCO/NO-based metrics.

Detailed description

The combined measurement of the pulmonary diffusing capacity to carbon monoxide (CO) and nitric oxide (NO) (DLCO/NO) has recently been standardised and validated for clinical use. It is thus ideal for assessing acute changes in pulmonary diffusing capacity and its components during various physiological manoeuvres. These changes are thought to involve acute changes in pulmonary perfusion and are notably relevant for patients with chronic obstructive pulmonary disease (COPD), in which they may be related to exertional dyspnoea. The aim of the present study is to investigate the effects of acute exercise on pulmonary diffusing capacity, and to determine the day-to-day repeatability of such assessments.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTAcute exerciseThe measurement will be repeated within one to seven days.

Timeline

Start date
2022-11-01
Primary completion
2023-05-01
Completion
2023-08-01
First posted
2022-10-17
Last updated
2022-11-21

Locations

2 sites across 1 country: Denmark

Source: ClinicalTrials.gov record NCT05583396. Inclusion in this directory is not an endorsement.